Evidence map›Paper›PMID 36261585›Full record

ArticleBritish journal of cancer2022

Clonal relationship and alcohol consumption-associated mutational signature in synchronous hypopharyngeal tumours and oesophageal squamous cell carcinoma.

Josephine Mun-Yee Ko, Chen Guo, Conghui Liu, Lvwen Ning, Wei Dai, Lihua Tao, Anthony Wing-Ip Lo, Carissa Wing-Yan Wong, Ian Yu-Hong Wong, Fion Siu-Yin Chan and 9 more

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Esophageal cancer: from pathogenesis to precision therapies.Signal transduction and targeted therapy · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 2 countries.

Josephine Mun-Yee Ko *Department of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.ORCID http://orcid.org/0000-0002-7997-331X
Chen Guo *Department of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Conghui Liu *Department of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Lvwen NingDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Wei DaiDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.ORCID http://orcid.org/0000-0002-5558-0685
Lihua TaoDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.ORCID http://orcid.org/0000-0001-8811-8094
Anthony Wing-Ip LoDivision of Anatomical Pathology, Queen Mary Hospital, Hong Kong (Special Administrative Region), People's Republic of China.ORCID http://orcid.org/0000-0002-9388-310X
Carissa Wing-Yan WongDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.ORCID http://orcid.org/0000-0001-8130-2921
Ian Yu-Hong WongDepartment of Surgery, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Fion Siu-Yin ChanDepartment of Surgery, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Claudia Lai-Yin WongDepartment of Surgery, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Kwan Kit ChanDepartment of Surgery, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Tsz Ting LawDepartment of Surgery, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.
Nikki Pui-Yue LeeDepartment of Surgery, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China.ORCID http://orcid.org/0000-0002-5750-8361
Zhichao LiuDepartment of Thoracic Surgery, Section of Esophageal Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.ORCID http://orcid.org/0000-0003-3542-0905
Haoyao JiangDepartment of Thoracic Surgery, Section of Esophageal Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Zhigang LiDepartment of Thoracic Surgery, Section of Esophageal Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China. dr_lizhigang@163.com.
Simon LawDepartment of Surgery, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China. slaw@hku.hk.
Maria Li LungDepartment of Clinical Oncology, University of Hong Kong, Hong Kong (Special Administrative Region), People's Republic of China. mlilung@hku.hk.ORCID http://orcid.org/0000-0003-2559-3626
University of Hong Kong · HKShanghai Jiao Tong University · CNQueen Mary Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe patients with dual oesophageal squamous cell carcinoma (ESCC) and hypopharyngeal cancer (HPC) have poor prognosis; their underlying genetic pathogenesis is unclear. We hypothesise that development of synchronous ESCC/HPC depends on multicentricity or independent origin, rather than multifocality due to local or lateral spreading.

methodMultiple region whole-exome sequencing (M-WES) and clonality analysis were used to assess clonal relationship and spatial inter- or intra-tumour heterogeneity (ITH) in 62 tumour regions from eight dual ESCC/HPC and ten ESCC patients.

resultsAll synchronous ESCC/HPC patients had COSMIC 16 mutation signatures, compared to only 40% ESCC in the current study (p = 0.013) and public data set (n = 165, p = 0.003). This alcohol consumption-related mutation signature 16, commonly involved in multiple alcohol-related cancers, was significantly associated with drinking and alcohol metabolism-related ADH1B rs1229984. The mutational landscape and copy number profiles were completely distinct between the two primary tumours; clonality analysis further suggested the two primary tumours shared no or only one clone accompanying independent subclone evolution. M-WES strategy demonstrated higher sensitivity and accuracy for detection of mutational prevalence and the late branch mutations among different regions in the ESCC tumours, compared to traditional sequencing analysis based on single biopsy strategy. Patients with high ITH assessed by cancer cell fraction analysis after M-WES were significantly associated with both relapse and survival.

conclusionsOur hypothesis-generating M-WES ITH assessment data have implications for prognostication. Collectively, our findings support multicentric independent clonal evolution, the field cancerisation theory, and suggest novel insights implicating an aetiologic role of alcohol metabolism in dual ESCC/HPC carcinogenesis.

Indexed as

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaHypopharyngeal NeoplasmsAlcohol DrinkingHumansMutation

Identifiers

PMID36261585
PMCPMC9726980
OpenAlexW4306822615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.